Vyepti
(Eptinezumab)
Provider Summary
Primary Uses
Preventive treatment of migraine in adults
Mechanism of action
Monoclonal antibody targeting CGRP ligand, reducing migraine signaling.
Pre-treatment / baseline requirements
Review migraine diagnosis and prior preventive failures; screen for hypersensitivity history; pregnancy status when applicable.
Common side effects
Nasopharyngitis, hypersensitivity-related symptoms.
Serious adverse effects / key risks
Hypersensitivity including anaphylaxis (rare).
Referral requirements
Standard infusion referral form + drug-specific checklist
Patient & Caregiver Education
What it treats
Preventive treatment of migraine in adults
How it works
Blocks CGRP signaling to help prevent migraines.
Before treatment
Tell your clinician if you have an active infection/fever, are pregnant/planning pregnancy, or have major heart/nerve problems. Depending on the medication, you may need labs or screening tests (e.g., TB/hepatitis) and a vaccine review.
Common side effects
Nasopharyngitis, hypersensitivity-related symptoms.
Get urgent help for
Hypersensitivity including anaphylaxis.
On treatment day
Plan to stay for monitoring. If you feel dizzy, drowsy, or unwell afterward, do not drive and follow your clinician’s instructions.